<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="news" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="iso-abbrev">Reactions Weekly</journal-id><journal-id journal-id-type="pmc-domain-id">3814</journal-id><journal-id journal-id-type="pmc-domain">phenaturepg</journal-id><journal-title-group><journal-title>Reactions Weekly</journal-title></journal-title-group><issn pub-type="ppub">0114-9954</issn><issn pub-type="epub">1179-2051</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer Nature - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8195731</article-id><article-id pub-id-type="pmcid-ver">PMC8195731.1</article-id><article-id pub-id-type="pmcaid">8195731</article-id><article-id pub-id-type="pmcaiid">8195731</article-id><article-id pub-id-type="doi">10.1007/s40278-021-97265-7</article-id><article-id pub-id-type="publisher-id">97265</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Flucloxacillin/paracetamol</article-title><subtitle>High-anion gap metabolic acidosis : case report</subtitle></title-group><pub-date pub-type="epub"><day>12</day><month>6</month><year>2021</year></pub-date><pub-date pub-type="ppub"><year>2021</year></pub-date><volume>1859</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">383650</issue-id><fpage>169</fpage><lpage>169</lpage><pub-history><event event-type="pmc-release"><date><day>12</day><month>06</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>15</day><month>06</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2021-06-16 00:16:32.380"><day>16</day><month>06</month><year>2021</year></date></event></pub-history><permissions><copyright-statement>&#169; Springer International Publishing AG 2021</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="40278_2021_Article_97265.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Switzerland AG 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<bold>Author Information</bold>
<list list-type="bullet"><title>An event is serious (based on the ICH definition) when the patient outcome is:</title><list-item><p>* death</p></list-item><list-item><p>* life-threatening</p></list-item><list-item><p>* hospitalisation</p></list-item><list-item><p>* disability</p></list-item><list-item><p>* congenital anomaly</p></list-item><list-item><p>* other medically important event</p></list-item></list></p><p>A 69-year-old man developed high-anion gap metabolic acidosis (HAGMA) following treatment with flucloxacillin and paracetamol [<italic toggle="yes">routes and dosages not stated</italic>].</p><p>The malnourished man had a history of vitamin-B deficiency, diabetes mellitus and chronic inflammation. He was referred to the emergency department with complaints of malaise, lower back pain and inflammation. Recently, he was diagnosed with mitral valve endocarditis secondary to <italic toggle="yes">Staphylococcus aureus, </italic>for which he was treated with flucloxacillin. Positron emission tomography-computed tomography (PET/CT) affirmed spondylodiscitis. He was then treated with paracetamol [acetaminophen] for pain relief. During admission, he was diagnosed with COVID-19. Twenty-one days after the initial presentation, he became confused and had abdominal pain and vomiting. Laboratory workup showed a metabolic acidosis with respiratory compensation and a high anion gap. Gas chromatography-mass spectrometry (GC/MS) showed a strongly elevated serum and urine 5-oxoproline and creatinine. As he had received flucloxacillin and acetaminophen, which were known causes of elevated 5-oxoproline. He was diagnosed with HAGMA secondary to flucloxacillin and paracetamol [<italic toggle="yes">time to reaction onset not stated</italic>].</p><p>Thereafter, paracetamol was discontinued and he was treated with piperacillin/tazobactam. Following this, the HAGMA resolved. For HAGMA, his malnutrition, vitamin B deficiency, diabetes mellitus, chronic inflammation and COVID-19 infection were also considered as risk factors.</p></body><back><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><mixed-citation publication-type="other">Eeckhout K, et al. Multiple factors in a COVID-19 patient leading to an elevated 5-oxoproline as a cause of high-anion gap metabolic acidosis: A case report. Clinical Toxicology 59: 596 (plus poster), No. 6, Jan 2021. Available from: URL: 
<pub-id pub-id-type="doi">10.1080/15563650.2021.1906080</pub-id> [abstract]</mixed-citation></ref></ref-list></back></article></pmc-articleset>